EWS-WT1 oncoprotein activates neuronal reprogramming factor ASCL1 and promotes neural differentiation

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Desmoplastic small round-cell tumors (DSRCT) are aggressive soft tissue sarcomas characterized by the EWS-WT1 fusion gene.
• The precise mechanism by which EWS-WT1 drives tumorigenesis remains incompletely understood.
• Understanding EWS-WT1's function is critical for developing effective DSRCT treatments.

Purpose of the Study:

• To elucidate the mechanistic basis of EWS-WT1's pathogenic activity in DSRCT.
• To investigate the role of EWS-WT1 in regulating neural gene expression.
• To explore potential therapeutic strategies targeting neural differentiation in DSRCT.

Main Methods:

• Generation of a transgenic mouse model for physiologic EWS-WT1 expression.
• Analysis of gene expression changes in embryonic fibroblasts and DSRCT cells.
• Chromatin immunoprecipitation to assess EWS-WT1 binding to the ASCL1 promoter.
• Silencing of EWS-WT1 and assessment of DSRCT cell viability and differentiation.

Main Results:

• EWS-WT1 expression induced significant upregulation of neuronal genes, including the neural reprogramming factor ASCL1.
• EWS-WT1 directly binds to the ASCL1 promoter, activating its transcription.
• Silencing EWS-WT1 reduced ASCL1 expression, DSRCT cell viability, and neural differentiation markers.
• DSRCT cells exposed to neuronal induction media showed increased neural gene expression and neurite-like projections, which were blocked by EWS-WT1 silencing.

Conclusions:

• EWS-WT1 activates neural gene expression and promotes partial neural differentiation in DSRCT, primarily through ASCL1.
• Targeting neural differentiation pathways may represent a novel therapeutic avenue for DSRCT.
• Further research into EWS-WT1's role in neural reprogramming could uncover new treatment strategies.